Mohit Bansal
Stock Analyst at Wells Fargo
(4.66)
# 824
Out of 4,596 analysts
779
Total ratings
58.1%
Success rate
10.4%
Average return
Main Sectors:
Stocks Rated by Mohit Bansal
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABBV AbbVie | Maintained: Buy | $295 | $250.94 | +17.56% | 42 | Aug 3, 2026 | |
| BMY Bristol-Myers Squibb Company | Rated: Hold | $60 → $65 | $65.31 | -0.47% | 44 | Jul 31, 2026 | |
| NBIX Neurocrine Biosciences | Rated: Buy | $200 | $166.80 | +19.90% | 33 | Jul 31, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Hold | $700 → $750 | $762.63 | -1.66% | 67 | Jul 31, 2026 | |
| BIIB Biogen | Maintained: Buy | $250 | $202.95 | +23.18% | 54 | Jul 30, 2026 | |
| SMMT Summit Therapeutics | Maintained: Buy | $30 | $13.02 | +130.41% | 12 | Jul 27, 2026 | |
| MRK Merck & Co. | Maintained: Buy | $150 | $130.20 | +15.21% | 53 | Jul 24, 2026 | |
| MIST Milestone Pharmaceuticals | Maintained: Buy | $8 → $7 | $1.11 | +530.63% | 4 | Jul 22, 2026 | |
| JAZZ Jazz Pharmaceuticals | Rated: Buy | $265 → $285 | $252.86 | +12.71% | 18 | Jul 14, 2026 | |
| AMGN Amgen | Maintained: Hold | $390 | $385.16 | +1.26% | 48 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $550 | $477.10 | +15.28% | 51 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1,280 | $1,148.84 | +11.42% | 67 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $165 | $130.21 | +26.72% | 63 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 | $32.10 | +118.07% | 9 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $28 | $25.01 | +11.96% | 51 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $75 | $82.54 | -9.13% | 26 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $65 | $55.89 | +16.30% | 22 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $140 → $140 | $90.58 | +54.56% | 10 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $75 | $60.02 | +24.96% | 25 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $4.23 | +18.20% | 16 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $5.51 | +135.93% | 1 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 | $25.52 | +115.52% | 15 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $47 | $62.67 | -25.00% | 13 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $84.65 | n/a | 1 | Jul 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $14 | $27.24 | n/a | 2 | Jun 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $3 | $0.0001 | n/a | 1 | Jun 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $52 | $1.04 | n/a | 1 | Apr 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 → $75 | $76.60 | n/a | 3 | Mar 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $33 | $35.50 | n/a | 2 | Mar 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $27 | $1.41 | n/a | 6 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 → $75 | $7.07 | n/a | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $5 | $0.0003 | n/a | 5 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $75 → $65 | $30.02 | n/a | 5 | Dec 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 → $8.5 | $3.10 | n/a | 4 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $5 | $0.032 | n/a | 2 | Apr 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $13.78 | n/a | 1 | Jun 11, 2019 |
AbbVie
Aug 3, 2026
Maintained: Buy
Price Target: $295
Current: $250.94
Upside: +17.56%
Bristol-Myers Squibb Company
Jul 31, 2026
Rated: Hold
Price Target: $60 → $65
Current: $65.31
Upside: -0.47%
Neurocrine Biosciences
Jul 31, 2026
Rated: Buy
Price Target: $200
Current: $166.80
Upside: +19.90%
Regeneron Pharmaceuticals
Jul 31, 2026
Maintained: Hold
Price Target: $700 → $750
Current: $762.63
Upside: -1.66%
Biogen
Jul 30, 2026
Maintained: Buy
Price Target: $250
Current: $202.95
Upside: +23.18%
Summit Therapeutics
Jul 27, 2026
Maintained: Buy
Price Target: $30
Current: $13.02
Upside: +130.41%
Merck & Co.
Jul 24, 2026
Maintained: Buy
Price Target: $150
Current: $130.20
Upside: +15.21%
Milestone Pharmaceuticals
Jul 22, 2026
Maintained: Buy
Price Target: $8 → $7
Current: $1.11
Upside: +530.63%
Jazz Pharmaceuticals
Jul 14, 2026
Rated: Buy
Price Target: $265 → $285
Current: $252.86
Upside: +12.71%
Amgen
Jul 13, 2026
Maintained: Hold
Price Target: $390
Current: $385.16
Upside: +1.26%
Jul 13, 2026
Rated: Buy
Price Target: $550
Current: $477.10
Upside: +15.28%
Jul 10, 2026
Maintained: Buy
Price Target: $1,280
Current: $1,148.84
Upside: +11.42%
Jul 9, 2026
Maintained: Buy
Price Target: $165
Current: $130.21
Upside: +26.72%
Jul 7, 2026
Maintained: Buy
Price Target: $70
Current: $32.10
Upside: +118.07%
Jun 22, 2026
Maintained: Hold
Price Target: $28
Current: $25.01
Upside: +11.96%
Jun 15, 2026
Rated: Hold
Price Target: $75
Current: $82.54
Upside: -9.13%
Jun 11, 2026
Maintained: Buy
Price Target: $50 → $65
Current: $55.89
Upside: +16.30%
May 22, 2026
Maintained: Buy
Price Target: $140 → $140
Current: $90.58
Upside: +54.56%
May 21, 2026
Rated: Buy
Price Target: $75
Current: $60.02
Upside: +24.96%
May 5, 2026
Maintained: Hold
Price Target: $5
Current: $4.23
Upside: +18.20%
Apr 1, 2026
Maintained: Buy
Price Target: $13
Current: $5.51
Upside: +135.93%
Mar 13, 2026
Maintained: Buy
Price Target: $55
Current: $25.52
Upside: +115.52%
Aug 12, 2025
Maintained: Buy
Price Target: $47
Current: $62.67
Upside: -25.00%
Jul 2, 2021
Reiterated: Buy
Price Target: $95
Current: $84.65
Upside: n/a
Jun 29, 2021
Maintained: Buy
Price Target: $30 → $14
Current: $27.24
Upside: n/a
Jun 4, 2021
Initiated Coverage: Buy
Price Target: $3
Current: $0.0001
Upside: n/a
Apr 5, 2021
Initiated Coverage: Buy
Price Target: $52
Current: $1.04
Upside: n/a
Mar 26, 2021
Initiated Coverage: Buy
Price Target: $15 → $75
Current: $76.60
Upside: n/a
Mar 24, 2021
Maintained: Buy
Price Target: $20 → $33
Current: $35.50
Upside: n/a
Feb 25, 2021
Maintained: Buy
Price Target: $25 → $27
Current: $1.41
Upside: n/a
Jan 20, 2021
Maintained: Buy
Price Target: $36 → $75
Current: $7.07
Upside: n/a
Jan 5, 2021
Maintained: Buy
Price Target: $10 → $5
Current: $0.0003
Upside: n/a
Dec 23, 2020
Maintained: Buy
Price Target: $75 → $65
Current: $30.02
Upside: n/a
Sep 15, 2020
Maintained: Hold
Price Target: $11 → $8.5
Current: $3.10
Upside: n/a
Apr 27, 2020
Maintained: Buy
Price Target: $8 → $5
Current: $0.032
Upside: n/a
Jun 11, 2019
Initiated Coverage: Buy
Price Target: $21
Current: $13.78
Upside: n/a